Home › NDC Lookup › RxCUI directory › RxCUI 643173

Dasatinib 20 MG Oral Tablet [Sprycel] — RxCUI 643173

RxNorm drug concept · Semantic branded drug
RxCUI 643173 Semantic branded drug · SBD ● Current RxNorm concept 6 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI643173
Official nameDasatinib 20 MG Oral Tablet [Sprycel]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asSprycel 20 MG Oral Tablet
FDA products mapped6
Package NDCs mapped6
Reported Medicaid activity (SDUD)6,314 prescriptions · 22 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Dasatinib: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats certain leukemias that carry the Philadelphia chromosome. These are Ph+ chronic myeloid leukemia (CML) and Ph+ acute lymphoblastic leukemia (ALL). The exact approval depe...
  • Take it by mouth once a day, with or without food. Swallow the tablet whole. Do not crush, cut or chew it. Follow your prescriber’s directions for your dose.
  • Expect possible low blood counts, fluid retention, diarrhea, headache, rash, fatigue, nausea and shortness of breath. Call your doctor for bleeding, fever, swelling or trouble brea...
  • Usually not. H2 blockers and proton pump inhibitors can lower dasatinib levels, so they should not be used with it. If you need an antacid, take it at least 2 hours before or after...
📖 Read our full Dasatinib guide →

🕸️ Concept Web — How Dasatinib 20 MG Oral Tablet [Sprycel] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Dasatinib 20 MG Oral Tablet [Sprycel] RxCUI 643173

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Dasatinib 475342
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Sprycel 643170
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Dasatinib Oral Tablet 643104
    • Dasatinib Oral Product 1157186
    • Dasatinib Pill 1157187
    • Dasatinib Oral Tablet [Sprycel] 643172
    • Sprycel Oral Product 1177781
    • Sprycel Pill 1177782
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Dasatinib 20 MG Oral Tablet SCD · 643105
  • Dasatinib 20 MG SCDC · 643103
  • Dasatinib Oral Tablet SCDF · 643104
  • Dasatinib Oral Product SCDG · 1157186
  • Dasatinib Pill SCDG · 1157187

Brand-Name Concepts

  • Dasatinib 20 MG [Sprycel] SBDC · 643171
  • Dasatinib Oral Tablet [Sprycel] SBDF · 643172
  • Sprycel Oral Product SBDG · 1177781
  • Sprycel Pill SBDG · 1177782
  • Sprycel BN · 643170

📦 FDA Products & Package NDCs

6 products · 6 package NDCs
6 package NDCs map to RxCUI 643173 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00003-0524-11 1 BOTTLE in 1 CARTON (0003-0524-11) / 60 TABLET in 1 BOTTLE SPRYCEL E.R. Squibb & Sons, L.L.C. 2006-06-27
00003-0527-11 1 BOTTLE in 1 CARTON (0003-0527-11) / 60 TABLET in 1 BOTTLE SPRYCEL E.R. Squibb & Sons, L.L.C. 2006-06-27
00003-0528-11 1 BOTTLE in 1 CARTON (0003-0528-11) / 60 TABLET in 1 BOTTLE SPRYCEL E.R. Squibb & Sons, L.L.C. 2006-06-27
00003-0852-22 1 BOTTLE in 1 CARTON (0003-0852-22) / 30 TABLET in 1 BOTTLE SPRYCEL E.R. Squibb & Sons, L.L.C. 2008-05-30
00003-0855-22 1 BOTTLE in 1 CARTON (0003-0855-22) / 30 TABLET in 1 BOTTLE SPRYCEL E.R. Squibb & Sons, L.L.C. 2010-10-28
00003-0857-22 1 BOTTLE in 1 CARTON (0003-0857-22) / 30 TABLET in 1 BOTTLE SPRYCEL E.R. Squibb & Sons, L.L.C. 2010-10-28
Observed labelers: E.R. Squibb & Sons, L.L.C. (6) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.